Dr. Reddy's Laboratories has received Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for FTO VII, the company’s formulations manufacturing facility at Duvvada, Visakhapatnam.
This site was included in the warning letter received from USFDA in November, 2015. Subsequently, the site was audited by USFDA in March, 2017 for which the company received EIR in November, 2017, wherein the site's status remained unchanged. The site was again audited in October, 2018. Based on the company’s responses and follow up actions, the USFDA has concluded that this inspection is 'closed' and has determined the inspection classification of this facility as Voluntary Action Initiated (VAI).
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1676.00 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1235.05 |
| Zydus Lifesciences | 941.20 |
| Lupin | 2330.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: